Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Other Non Operating Income (2018 - 2026)

AC Immune has reported Other Non Operating Income over the past 9 years, most recently at -$224752.8 for Q1 2026.

  • Quarterly Other Non Operating Income rose 30.8% to -$224752.8 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Mar 2026, up 16.87% year-over-year, with the annual reading at -$3.5 million for FY2025, 92.26% down from the prior year.
  • Other Non Operating Income was -$224752.8 for Q1 2026 at AC Immune, up from -$362839.2 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $2.2 million in Q4 2024 and troughed at -$3.1 million in Q3 2024.
  • The 5-year median for Other Non Operating Income is -$55139.3 (2023), against an average of -$387889.3.
  • The largest YoY upside for Other Non Operating Income was 3451.49% in 2024 against a maximum downside of 15460.19% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$113144.4 in 2022, then crashed by 1361.7% to -$1.7 million in 2023, then surged by 235.63% to $2.2 million in 2024, then crashed by 116.18% to -$362839.2 in 2025, then soared by 38.06% to -$224752.8 in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Other Non Operating Income are -$224752.8 (Q1 2026), -$362839.2 (Q4 2025), and -$15001.3 (Q3 2025).